These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 28474588

  • 21. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA, Baillie E.
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [Abstract] [Full Text] [Related]

  • 22. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants.
    Murat I, Moriette G, Blin MC, Couchard M, Flouvat B, De Gamarra E, Relier JP, Dreyfus-Brisac C.
    J Pediatr; 1981 Dec; 99(6):984-9. PubMed ID: 7310594
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X, Zhang HT, Lyu Y, Wang LF, Yang ZY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S, Arand J, Engel C, Poets CF.
    Neonatology; 2014 Jun; 105(2):108-11. PubMed ID: 24335098
    [Abstract] [Full Text] [Related]

  • 30. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G, Fabbri L, Polackova R, Kiechl-Kohlendorfer U, Papagaroufalis K, Saenz P, Ferrari F, Lasagna G, Carnielli VP, Peyona® PASS Group.
    Neonatology; 2016 Jun; 109(3):221-7. PubMed ID: 26820884
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T, Balch AH, Ward RM, Korgenski EK, Sherwin CM.
    BMC Pharmacol Toxicol; 2016 Jun 07; 17(1):22. PubMed ID: 27266401
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of caffeine in infants unresponsive to theophylline in apnea of prematurity.
    Davis JM, Spitzer AR, Stefano JL, Bhutani V, Fox WW.
    Pediatr Pulmonol; 1987 Jun 07; 3(2):90-3. PubMed ID: 3588062
    [Abstract] [Full Text] [Related]

  • 37. The xanthine treatment of apnea of prematurity.
    Lucey JF.
    Pediatrics; 1975 May 07; 55(5):584-6. PubMed ID: 1128983
    [No Abstract] [Full Text] [Related]

  • 38. Role of L-carnitine in apnea of prematurity: a randomized, controlled trial.
    O'Donnell J, Finer NN, Rich W, Barshop BA, Barrington KJ.
    Pediatrics; 2002 Apr 07; 109(4):622-6. PubMed ID: 11927706
    [Abstract] [Full Text] [Related]

  • 39. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
    Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA.
    Pharmacotherapy; 2000 Jun 07; 20(6):644-52. PubMed ID: 10853619
    [Abstract] [Full Text] [Related]

  • 40. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM.
    Paediatr Drugs; 2014 Apr 07; 16(2):169-77. PubMed ID: 24399614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.